Average Co-Inventor Count = 9.44
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (12 from 3,923 patents)
12 patents:
1. 10112926 - Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors
2. 10004732 - Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
3. 9643983 - Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives
4. 9303035 - Substituted pyrazino[1',2′:1,2]pyrrolo[3,4-d]pyrimidines, pyrimido[4′,5′:3,4]pyrrolo[2,1-c][1,4]oxazines and pyrimido[4′,5′:3,4]pyrrolo[1,2-d][1,4]oxazepines for inhibiting the CFTR channel
5. 9139586 - Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives
6. 8901134 - Pyrazolo [3,4-D] pyrimidine derivatives useful to treat respiratory disorders
7. 8697687 - Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives
8. 8129541 - 5-phenylthiazole derivatives and use as PI3 kinase inhibitors
9. 8039472 - Pyrazine-2-carboxamide derivatives to treat diseases mediated by blockade of the epithelial sodium channel
10. 8017608 - 5-Phenylthiazole derivatives and their use as p13 kinase inhibitors
11. 7902375 - 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylin ositol 3 kinase enzymes (PI13) for treatment of inflammatory diseases
12. 7687637 - 5-phenylthiazole derivatives and use as Pi3 kinase inhibitors